Free Trial

HC Wainwright's Rating of 12244 (ASM.V) on 8/19/2019

On August 19, 2019, HC Wainwright updated its outlook on 12244 (ASM.V) (CVE:ASM) with the action "Boost Price Target", setting a price target of C$1.75. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from HC Wainwright

DateCompanyAction
9/18/2025
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
Boost Price Target
9/18/2025
Arqit Quantum Inc. stock logo
ARQQ
Arqit Quantum
Reiterated Rating
9/18/2025
Vertical Aerospace Ltd. stock logo
EVTL
Vertical Aerospace
Reiterated Rating
9/18/2025
MannKind Corporation stock logo
MNKD
MannKind
Reiterated Rating
9/18/2025
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
Downgrade
9/18/2025
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
Boost Price Target
More Ratings From HC Wainwright